Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement in Opioid-Induced Hypogonadism
NCT02433730Phase 4Completed
- Start
- May 2015
- Primary completion
- Sep 2019
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of testosterone undecanoate in hypogonadotropic hypogonadism (HH). Started May 2015; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT02433730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02433730.